Montag A & Associates Inc. Sells 950 Shares of Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD)
Montag A & Associates Inc. lessened its position in Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD – Free Report) by 49.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 974 shares of the company’s stock after selling 950 shares during the quarter. Montag A […]
More Stories
Critical Review: i-80 Gold (IAUX) & Its Rivals
i-80 Gold (NYSE:IAUX – Get Free Report) is one of 114 publicly-traded companies in the “Gold & silver ores” industry,...
Hillman Solutions Corp (NASDAQ:HLMN) Receives $14.20 Average Target Price from Analysts
Hillman Solutions Corp (NASDAQ:HLMN – Get Free Report) has earned an average rating of “Moderate Buy” from the six ratings...
Equity Residential (NYSE:EQR) Receives Consensus Rating of “Hold” from Analysts
Equity Residential (NYSE:EQR – Get Free Report) has been assigned a consensus rating of “Hold” from the nineteen brokerages that...
Comparing NLS Pharmaceutics (NASDAQ:NLSP) and Atossa Therapeutics (NASDAQ:ATOS)
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) and NLS Pharmaceutics (NASDAQ:NLSP – Get Free Report) are both small-cap medical companies,...
Contrasting Globalstar (GSAT) & Its Rivals
Globalstar (NYSEARCA:GSAT – Get Free Report) is one of 32 publicly-traded companies in the “Communication services, not elsewhere classified” industry,...
Head-To-Head Contrast: AIM ImmunoTech (NYSE:AIM) versus INmune Bio (NASDAQ:INMB)
INmune Bio (NASDAQ:INMB – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free Report) are both small-cap medical companies,...